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Endotoxic lipopolysaccharide  (LPS)  is  a  potent inflammatory agent,  and 
thus can serve as a valuable tool in studying the inflammatory response. Re- 
cent morphological studies showed that LPS, as well as the bacterial cell from 
which  it was  derived,  when incubated in fresh serum,  developed defects or 
"lesions" similar to those seen on erythrocytes undergoing immune hemolysis 
(1,  2).  LPS, like the sensitized red cell,  developed these lesions by means of 
complement (C  ~)  system activation (2).  Furthermore, it was recently shown 
that during the LPS-C  t interaction, all of the terminal C  p components (Ct3, 
Ct5,  C'6,  C'7,  CtS,  and C'9)  are  "fixed" or utilized (3).  Utilization of those 
components associated with the biological effects subserved by the C  ~ system 
(4, 5) suggested that certain aspects of endotoxin-induced inflammation might 
be mediated by C' (3). 
Accumulation of polymorphonuclear leukocytes (PMN's)  at the site of in- 
jection is  a  prominent characteristic  of inflammation induced by endotoxin 
(6,  7).  Information relating to  the mechanism by which endotoxin mediates 
this phenomenon would be useful in further understanding the inflammatory 
response in general. 
In 1962, Boyden developed a technique for the study of chemotaxis in vitro 
(8). He found that a factor (referred to in the singular for convenience, though 
multiple factors may be involved) chemotactic for PMN's was generated when 
immune precipitates were incubated with fresh rabbit serum, and speculated 
that a  serum system like  C  ~ might be involved.  One group using Boyden's 
technique showed that aggregated human gamma globulins  (AHGG)  in the 
presence of fresh serum generated a chemotactic factor, but presented evidence 
against  C'  being  associated  with  its  generation  (9).  Subsequently,  it  was 
shown that a chemotactic factor could be generated from purified human and 
guinea pig C  ~ components or whole rabbit serum upon interaction with im- 
mune precipitates or sensitized sheep erythrocytes. Furthermore, the chemo- 
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tactic  activity  was  associated  with  a  trimolecular  complex  of  C15,  C'6,  and 
CS7  (10,  11).  More  recently  it  was  found  that  LPS,  in  the  presence  of fresh 
serum,  generated  a  chemotacfic factor for PMN's,  but  the relationship  of the 
C s system  to  this chemotactic factor was not established  (12). 
This report presents evidence that LPS in the presence of fresh serum gener- 
ates neutrophil  chemotactic factor in vitro by means  of C ~ system  activation. 
This chemotactic factor is a  heat-stable,  low molecular weight (15,000-30,000) 
product  and  as such is different from previously described  chemotactic factors 
derived from the C ~ system  (10,  11,  13). 
Materials  and Methods 
Endotoxi~  Lipopolysaccharide  (LPS).--The  LPS  used  in  most  of  the  experiments  was 
derived from Serratia  marcescens  by  the  trichloroacetic acid  extraction  procedure  as  pre- 
viously  described  (14). 1 A  detoxified  derivative  of  this  preparation  ("endotoxoid")  was 
prepared by deacylation with potassium methylate (15).1 LPS was also prepared from Veillo- 
nella  alcalescens by  the phenol-water extraction  procedure  of Westphnl and  Ltideritz  (16). 
AntiS.  marcescens  Antibody.--Rabbit  antiS,  marcescene serum  was  chromatographed 
on  Sephadex  G-200.  The  first  peak  eluted,  which  contained  2-mereaptoethanol-sensitive 
hemagglutinating activity for erythrocytes sensitized with S.  marcescens LPS, was used as 
the antibody source. 1 
Zymosan.--Zymosan  was  obtained  from  General  Biochemicals,  Chagrin  Fails,  Ohio. 
Immune Complexes  of Bovine  Serum Albumin  (BSA)  and  Rabbit  Antiserum  (Rabbit  Anti- 
BSA).--Crystalline  BSA was  obtained  from Pentex Inc.,  Kankakee,  Ill. Rabbit  anti-BSA 
was obtained from Hyland Laboratories, Los Angeles,  Calif., and contained 240/zg of anti- 
body nitrogen/m1,  z BSA and rabbit anti-BSA were reacted at equivalence for 24 hr at 4°C 
in the presence of 0.01 ~  EDTA. The precipitate was washed twice in EDTA-salifie, twice in 
saline, and resuspended in saline. Final protein concentrations were determined by the assay 
of Lowry et al. (17). 
Sources  of  Various  Mammalian  Sera.--Guinea  pig serum was obtained from Texas Bio- 
logicals,  Inc., Fort Worth, Texas. Normal human serum was provided by young adult male 
laboratory personnel and normal NIH blood bank donors. Rabbit serum was collected from 
adult New Zealand white rabbits. Sow serum was obtained from Minnesota miniature pigs.  3 
Mouse  serum  was  collected from  strains  B10.D2/Sn  "new"  (Ct-normal)  and  B10.D2/Sn 
"old"  (C'5-defieient) (18)  obtained from the Jackson  Memorial Laboratories,  Bar Harbor, 
Maine; the hemolytic C  ~ deficiency in the old line serum was confirmed by hemolytic assay. 
Rabbit  Peritoneal  PMN's.--Rabbit  PMN's  were  collected as  described  by  Hirsch  and 
Church (19) with the following modifications: 120 ml of 0.1% glycogen in normal saline con- 
raining 50 rag/100 ml neomycin was injected ifitraperitoneally in adult New Zealand rabbits 
6  hr before the  exudate was withdrawn.  The exudate was collected by injecting 60 ml of 
heparinized  saline  (2  units  heparin/ml)  intraperitoneally;  the  fluid  was  allowed  to  drain 
through a  perforated No.  15 needle into sterile conical centrifuge tubes.  The ceils were col- 
lected immediately prior to use and  suspended  in Gey's medium with 2%  BSA at pH  7.2 
containing added penicillin and streptomycin (Gey's medium). 
Incubation  Mixtures  for  Chemotactic  Factor  Generation.--Unless  stated  otherwise,  all 
incubation  mixtures contained 0.1  ml serum and 0.1  ml test reagent diluted  to  1 ml with 
1 Generously provided by Dr. A. Nowotny. 
Kindly determined by Dr. L. Lichtenstein. 
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Gey's medium.  The reaction mixtures were incubated in water baths at 37°C  for 30 rain 
followed by 56°C for 30 rain. The reaction mixtures were then diluted to 3.0 ml with Gey's 
medium.  Test  reagents were diluted  in gelatin-Veronal-bugered saline supplemented with 
Mg  ++ and Ca  ++ (GVB++). 
~t~antitation  of  C/~mota~.--The  assay  system  used  was  as  described  by  Boyden  (8) 
with the following modifications: 1.2/a Millipore discs were used  (obtained from Millipore 
Filter Corp., New Bedford, Mass.). The number of cells per high power field was determined 
by inverting the Millipore disc after staining and clearing, and placing it bottom side up on a 
standard microscope slide. Any calls seen on the surface of the disc had to migrate through 
its entire width. Only cells on the surface of the disc were counted using the 40X  objective 
with the aid of a microgrid. The average number of ceils in 10 random fields was determined 
for each disc. 
Sagittal  Vie~vs of Millipore D/scs.--Millipore discs incubated with PMN's and with nor- 
mal  guinea pig  serum,  or with a  guinea pig-LPS  incubation mixture were  prepared  and 
stained as previously described (8). The Miliipore discs were then imbedded in parafifin and 
10 #  sections were prepared.  The sections were counterstained with eosin and fixed  using 
standard methods. Photomicrographs were taken of the sections to illustrate the migration 
of cells through the filter disc. 
Complement Fi~TJion.--The ability of LPS,  zymosan,  and BSA-anti-BSA complexes to 
fix C' was determined in reaction mixtures identical with those used in testing for their ability 
to generate the factor chemotactic for PMN's.  In this experiment, 0.1  ml of test reagent 
was reacted with 0.9 ml of guinea pig serum for 1 hr at 37°C. Residual total C ~ activity was 
measured by the method of Osier et ai.  (20), and residual classical C~3 (C'-EDTA)  activity 
was assayed with EA C'4,  2a by minor modifications (21)  of the methods of Mayer  (22). 
This classical C'3 activity is now known to consist of at least six separate proteins termed 
CI3, C'5, CI6, CI7, el8, and C'9 (4, 5). 
The effect of antibody upon the ability of "endotoxoid" to fix C ~ also was tested in parallel 
with tests of its effect on the ability of endotoxoid to induce generation of the chemotactic 
factor. In this experiment, 0.4 ml antiS, marcescens antibody, 0.1  ml containing 50/~g of 
endotoxoid and 0.5 ml of a  1:5 dilution of guinea pig serum (containing 15 CtHs0) were incu- 
bated at 37°C for 60 rain. Residual total C' activity was determined by the method of Osier 
et al. (20). 
To assay C' activity in small volumes of mouse serum, washed chicken erythrocytes were 
presensltized with rabbit anti-chicken erythrocyte serum in the presence of 0.01 ~  EDTA. 
After two washings, the sensitized ceils (2 X  108/ml) were suspended in GVB++. Serial dilu- 
tions of mouse serum  (0.025  ml) were incubated with 0.025 ml of GVB  ++ and 0.025 ml of 
sensitized ceils for 60 rain at 37°C in Microtiter plates  (Cook Engineering Co., Alexandria, 
Va.); the plates were centrifuged and hemolysis was scored according to Nelson et ai.  (23). 
Ckromatography.--Guinea  pig serum (5.4 ml) was incubated with 0.6 ml GVB  ++ contain- 
ing 125 #g S. marcescens LPS for 45 rain at 37°C followed by 30 min at 56°C. A 2.0 ml aliquot 
was chromatographed on a  G-100 Sephadex column (38 cm X  2.5 cm). Phosphate-buffered 
saline (PB8)  at pH 7.1  (0.02  x~ phosphate, 0.85% NaC1)  was used as the eluent. Blue dex- 
tran, hemoglobin, and cytochrome c were used as molecular markers. 1 ml aliquots of eluent 
fractions were diluted with 2.0 ml Gey's medium and tested for chemotactic activity as de- 
scribed. 
Sucrose Density Gradient Separation.--A linear density gradient of  10%--40% sucrose in 
PBS was prepared as previously described (24).  Samples to be separated by sucrose density 
gradient ultracentrifugation were prepared as follows: molecular markers consisting of cata- 
lase, bovine serum albumin, and cytochrome c  (0.4 mg of each in 0.2 ml of PBS); pooled 
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chromatography reconstituted  to one-fourth the original volume with  distilled water;  and 
chemotactic factor generated in whole fresh guinea pig serum with S. marcescats LPS. Sam- 
pies containing 0.6 ml of molecular markers, or pooled lyophilized chemotactic factor or whole 
serum in which chemotactic factor was generated, were layered on top of individual sucrose 
density gradients. The tubes were centrifuged at 35,000 rpm using a SW39 head in a model L 
Spinco ultracentrifuge for 16 to 18 hr at 5°C. Fractions containing approximately 0.4 ml were 
collected by puncturing the bottom of the centrifuge tube. The fractions were analyzed in a 
Beckman DB spectrophotometer at 280 nag, and 410 m/z, and also tested for chemotactic 
activity. 
RESULTS 
Quantitation of Chemotaxis Generated in Guinea Pig Serum by LPS.--Various 
concentrations of LPS preparations were incubated in guinea pig serum and 
TABLE I 
Chemotactio Factor Generation by LPS in Guinea Pig Serum 
Amount of LPS in reaction mixture* 
6,g) 
20 
5 
0.5 
0.05 
0.005 
Serum alone 
20 S. marcesccns LPS without serum 
5 V. alcales~s LPS without serum 
Exp. 1 
2000 
2000 
1608 
420 
96 
36 
96 
Cells per high power field 
Exp. 2  Exp. 3 
2000 
2000  1535 
888  i056 
6OO  24O 
400  228 
216  72 
36  0 
Exp. 4t 
1776 
836 
246 
108 
36 
48 
* Reaction mixture: 0.1 ml guinea pig serum and 0.1 ml of various concentrations of LPS 
diluted to 1.0 ml with Gey's medium. Incubation  at 37°C for 30 min followed by 56°C for 30 
rain. Controls consisted of 0.1 ml serum or LPS incubated with 0.9 ml Gey's medium. In 
Experiments 1-3, S. marcesc~s LPS was used, whereas V. alcal~sccns LPS was used in Ex- 
periment 4. 
~t Note photomicrographs taken of chemotactic response in Experiment 4 (Fig. 3). 
tested  for  their  chemotaxis-generating properties.  Decreasing  the  concentra- 
tion of LPS  in serum resulted in decreased  chemotaxis.  The results of three 
different experiments using S. marcescens LPS are shown in Table I. It should 
be noted that significant chemotaxis was generated with as little as 0.05  /~g 
of LPS.  This sensitivity has not been previously reported with other chemo- 
taxis-generating agents  employing the  Boyden chamber  technique or  modi- 
fications thereof.  The  highest  readings were  approximate  as  the  number of 
cells which  migrated  through  the filter were  densely packed  and sometimes 
difficult to distinguish with certainty. 
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V.  alcalescens  LPS  and  guinea pig serum  (Table I,  Fig.  3).  The cells which 
appear to be out of focus are those which have not quite migrated to the lower 
layer of the filter.  The gradation  of cells in each field as a  reflection  of the 
amount  of LPS  employed to generate  chemotaxis can be appreciated in  the 
photomicrographs. 
In addition,  sagittal sections through  the  Millipore  filter  show  the migra- 
tion of cells through the disc (Fig. 4). The migration of cells in a control prepa- 
ration  (serum alone)  is compared with the migration of cells incubated with 
chemotactic factor generated by a  serum-LPS reaction mixture.  One can see 
the length (approximately 150 t*) of the path through which the PMN's must 
migrate  to  reach  the  counting  surface.  As  can  be  seen  in  the  control  disc, 
during  the 3  hr incubation many PMN's have penetrated  the upper portion 
TABLE II 
Effects of Complement System Inhibition  or Inactivation on Chemotaxis Generation 
by LPS 
Reaction mixture* 
1. No inhibition 
2.  Incubation at O°C 
3. IncubationinEDTA 
4.  Preheated serum 
Chemotaxis (cells  per 
high power  field) 
1830 
340 
108 
65 
c' available  for fixation 
(C'H~) 
15 
<2 
<2 
<2 
* Reaction mixtures: i. As described in Materials and Methods using 0.i ml guinea pig 
serum and 5 #g LPS. 2. Initial incubation at 0°C for 30 min, then $6°C for 30 min. 3. Incuba- 
tion in the presence of 0.02 M EDTA. 4. Serum source preheated at 56°C for 30 rain prior to 
incubation. 
of the disc but few have migrated to the counting surface. In the test disc, a 
massive migration of PMN's to the counting surface is obvious. Sectioning of 
the  disc  in  this  manner  might  provide  alternate  methods  of  quantitating 
chemotaxis as well as studying kinetics of PMN migration. 
Effects  of Inhibiting  ttemolytic  C'  on  Chemotactic  Factor  Generat/~n.--Pre- 
heating  serum at 56°C  for 30 rain,  incubating  at 0°C  rather  than the usual 
37°C,  and incubating in the presence of 0.02 ~r EDTA,  all effectively dimin- 
ished  C' fixation (22).  Incubation of LPS in such sera generated little or no 
chemotacfic  factor  (Table  II).  Chemotaxis  generation  was  fully  restored 
when  a  37°C  incubation  followed the 0°C  incubation. 
Detoxified  preparations  of  LPS  ("endotoxoids")  are  deficient  in  certain 
biologic properties  characteristic  of LPS  and  are  also  deficient  in  C'-fixing 
properties which can be restored when anti-endotoxin serum is incubated with 
the endotoxoid  (15,  25).  Endotoxoid  serves as a  useful control  to determine 
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fresh sermn. The endotoxoid was found to be deficient in chemotactic generating 
properties. However, in the presence of rabbit antiS,  marcescens  antibody, the 
endotoxoid regained a capacity to generate chemotactic factor concomitant with 
the ability to fix hemolytic complement (Table III). 
The  ability of LPS  to generate chemotaxis was  tested in sera  of mice con- 
TABLE III 
C p Fixation and Chemotactic Factor Generation Using Endotoxoid  with and without 
A ntibody 
Incubation mixture*  C' fixation:~ 
,  % 
Endotoxoid alone  mar-  < 10 
Endotoxoid with  "heavy" fraction anti-S.  81 
cesoe~s antibody 
Chemotactlc factor 
generation (cells per 
high power field) 
48 
228 
* 50 #g endotoxoid incubated with 0.1 ml guinea pig serum alone or with addition of 0.4 
ml pooled antiS, marcescens antibody (see Materials and Methods). 
:~ Expressed as per cent of total available units ("fixed") (15 C'Hs0 available). 
TABLE IV 
Chemotactic Factor Generation by  LPS in  Cr5-Defident  Compared  to  Normal  Mouse  Serum 
Reaction mixture* 
B10. D2/Sn "old" and 10/zg LPS 
B10.D2/Sn "new" and 10 #g LPS 
B 10. D2/Sn "old" serum control without LPS 
B10. D2/Sn "new" serum control without LPS 
10 #g LPS without serum 
Exp. 1 
36 
264 
18 
48 
12 
Cells per high power field 
Exp. 2 
24 
228 
24 
3 
18 
Exp. 3 
36 
396 
12 
48 
12 
* 0.2 ml pooled mouse serum incubated with 10 #g LPS for 30 rain at 37°C followed by 
30 mill at 56°C. Controls incubated similarly. 
genitally Cl-deficient. Different strains of inbred mice vary greatly with respect 
to their hemolytic C p titers  (26, 27). Mice of the strains B10.D2/Sn  "old" and 
B10.D2/Sn "new" differ in that the old strain is completely devoid of C r meas- 
ured by the hemolytic assay while the new strain has normal mouse  C r titers 
(27). Furthermore, the C 1 deficiency in the old strain was found to be due to a 
complete lack of a serum protein analogous to human C'5 (18). The strains are 
otherwise coisogenic. While chemotactic factor was  generated by LPS  in  the 
new  strain  serum,  no  significant chemotactic factor  generation  is  detectable 
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Comparison  of  Chemotactic  Factor  Generation,  Hemolytic  C t  Fixation,  and 
Classical  C3 Fixation by V. alcalescens LPS, BSA-anti-BSA, and Zymosan in 
Guinea Pig Serum.--In this experiment, 0.9 ml of fresh guinea pig serum was 
incubated  with  various  quantities  of  V.  alcalescens  LPS,  BSA-anti-BSA, or 
zymosan. Chemotactic assays were otherwise the same as previously described. 
C t  fixation assays were  performed  to  determine  total hemolytic C~Hs0 units 
fixed and classical C'3 fixed (Table V). 
TABLE V 
Comparison of the Effects of V. alealescens LPS, Zymosan, and Preformed Complexes of BSA- 
Rabbit-Anti-BSA Upon Classical C'3, Total C' Hemolytic Activities, and 
Chemotactic Factor Generation in Undiluted Guinea Pig Serum* 
Material tested  Amount  Total C'  Classical C'3  Cells per high 
(C'-EDTA)  power field 
LPS 
LPS 
LPS 
LPS 
LPS 
Zymomn 
Zymomn 
Zymomn 
Zymosan 
,ug 
10 
25 
50 
100 
200 
25 
100 
200 
500 
<10 
25 
38 
43 
>67 
<10 
<10 
21 
41 
19 
52 
69 
83 
89 
<I0 
22 
30 
58 
BSA-anti-BSA 
BSA-anti-BSA 
BSA-anti-BSA 
BSA-anti-BSA 
None 
C' activity available 
33 
65 
130 
260 
<10 
26 
43 
63 
126 
19 
43 
49 
69 
819 
1044 
840 
1332 
1244 
1290 
252 
612 
1392 
1404 
348 
372 
408 
1116 
36 
* C' fixation expressed as per cent available C'. 
Significant chemotaxis could be seen wherever there was significant C' fixa- 
tion.  Chemotactic  factor  generation  was  detectable with  lower doses  of  test 
reagents  than  was  fixation of total hemolytic C 1,  or classical C'3.  This  may 
indicate that the chemotaxis assay is more sensitive than the hemolytic assay 
for detection of  C' fixation.  Chemotactic  factor generation was  more  closely 
correlated with fixation of the classical C'3 components than with total C' fixa- 
tion. 
Comparison of Sera of Various Species as Source of Chemotactic  Factor  Gen- 
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to determine if all could generate chemotacfic factor in the presence of LPS. 
All were found to do so but not to the same degree.  Guinea pig and sow sera 
were  the most potent sources  of  chemotactic factor  after  incubation with a 
constant amount of LPS (Table VI). In mouse, rabbit, and human sera, chemo- 
TABLE VI 
Ckemotactic  Factor Generation in Sera of Various Species 
Species (serum-LPS incubation mixtures) * 
Guinea pig (0.1 ml) 
Sow (0.1 ml) 
Mouse B10. D2/Sn "new"  (0.2 ml) 
Rabbit (0.2 ml) 
Human (0.3 ml) 
Cells  per high  power  field 
With LPS 
1830 
828 
264 
256 
276 
Serum  control 
120 
36 
3 
3 
12 
* The indicated volume of serum was incubated at 37°C for 30 min with 5 Izg S. marcescens 
LPS and diluted to a total volume of 1.0 ml with Gey's medium. 
4.0 
3.0 
::L 
E 
o 
IZ 
0 
o  2.0 
cO 
£M 
123 
0 
1.0 
O. 50 
0.25 
22  44 
•  OD  at 280rap. 
•  '  OD  ef410m/~ 
o  Cells/hlghpower  field 
(chemofaxis) 
~glob/n 
68, 000 
66  88  110 
I 
IOO0 
0 
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r- 
800  g 
3:: 
600  .-r. 
0 
400  m 
Cytochrome C  200  \  /2, 500 
152  t54  176  198  220 
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FIG. 1. G-100 Sephadcx separation of fresh guinea pig serum-LPS reaction mixture. The 
peak of chemotactic factor activity lies between the previously calibrated hemoglobin and 
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tactic factor generation could be reproducibly detected only when 0.2 ml or 0.3 
ml of sera was used in the reaction mixture. 
Characterization  of  Chemotactic Factor Generated by  LPS  in  Guinea Pig 
Serum.--Chemotactic factor generated by interaction of LPS with whole guinea 
pig serum was found to be heat stable (56°C) and nondialyzable. It furthermore 
maintained activity during storage at -- 70°C or O°C for 96 hr. Maximal genera- 
tion of chemotactic factor took place within 15 mln after incubation of serum 
and LPS at 37°C. 
Cytochrome 
C  I 
0.6 
0.5 
O.4 
o  ~a3 
~0.2 
0.I 
Catalase 
~,neratfng  fract/on$ 
from Sephadex 
\ Chromatograph2 
v  I  2  4  6  8  I0  12  14 
BOTTOM  TOP 
FRACTION  NUMBER 
FIG. 2.  Sucrose  density gradient  ultracentrifugation  of chemotactic factor  obtained  by 
pooling the fraction with chemotactic  activity from Sephadex chromatography.  The peak of 
chemotactic factor 280 m/~ absorption  is compared to molecular weight markers centrifuged 
simultaneously. 
Chemotactic  factor was generated in whole guinea pig serum by incubation 
with S. marcescens LPS and was separated on a G-100 Sephadex column. The 
elution volumes of blue dextran,  hemoglobin,  and  cytochrome  c were deter- 
mined and used as molecular weight markers. The peak of chemotactic  factor 
generation was eluted at a volume falling between that of hemoglobin and cyto- 
chrome c (Fig.  1)o 
Sucrose density gradient separation was performed using catalase,  albumin, 
and cytochrome c as molecular weight markers. An aliquot of the pooled peak of 
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on another sucrose density gradient and centrifuged simultaneously with the 
molecular weight markers. A sharp peak of the chemotactic factor protein was 
localized in the lighter fractions of the gradient. The relationship of the molecu- 
lar markers to the chemotactic factor is seen in Fig. 2. In addition, the chemo- 
tactic factor in whole serum was isolated by sucrose density gradient separation. 
The peak of chemotactic factor activity was again localized in the lighter frac- 
tions of the gradient. This supported the previous size characterization of the 
chemotactic factor by Sephadex chromatography. 
These  two  physical methods  of  isolating chemotactic  factor  indicate  its 
molecular weight to be between 12,400 and 68,000.  Furthermore, the elution 
volume (V,)  of the chemotactic factor as well as the void volume (Vo) of the 
G-100 Sephadex column was determined. These values were used to determine 
Kay  4 of the chemotactic factor. When this was plotted on a K~v vs. molecular 
weight scale for G-100 Sephadex, the molecular weight was estimated to be in 
the range of 15,000-30,000  (28). 
DISCUSSION 
There is an increasing awareness of the important role the complement sys- 
tem, and in particular the terminal components, can play as a mediator of the 
inflammatory response (4, 5). 
It has recently been shown that LPS fixes large amounts of those terminal C r 
components related to the biologic activity mediated by the complement system 
(3).  It has thus been suggested that the inflammatory response to endotoxin 
might be at least in part complement dependent (2). 
Injection of submicrogram quantities of LPS into the skin of rabbits or man 
leads to the accumulation of large numbers of PMN's within hours after injec- 
tion (6, 7). Appreciating the strong reactivity of endotoxin with the complement 
system, we investigated the possibility that the in vitro generation of factors 
chemotactic for rabbit PMN's by endotoxin in serum might be dependent upon 
complement system activation. 
The most suitable means for studying in vitro chemotaxis was found to be a 
minor modification of the method described by Boyden (8). Using a smaller pore 
size Millipore filter we reduced the background counts of serum controls and 
still were able to get high and reproducible cell counts in test situations. Signifi- 
cant PMN chemotaxis was recorded when submicrogram levels of LPS were 
incubated in fresh guinea pig serum. This indicates the assay system has a 
sensitivity not previously appreciated,  and detects chemotaxis generated by 
quantities of LPS approaching the lower limits which are able to produce in- 
flammation in vivo. 
In the present experiments, immune precipitates and zymosan as well as LPS 
4 K~v is the partition coefficient between the liquid phase  and the gel phase calculated for 
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generated chemotactic factor in fresh guinea pig serum. Chemotaxis generation 
could be detected using all these agents at dilutions too great to detect C' fixa- 
tion employing a standard hemolytic C' assay (22). Zymosan was less efficient 
in chemotaxis generation than LPS or immune precipitates when compared on a 
weight basis. This corresponds closely to what was seen in hemolytic C' fixation 
assays. 
Three lines of evidence demonstrated the requirement of the C' system for the 
generation of chemotactic factor by LPS in serum. First, LPS did not generate 
chemotaxis in sera so pretreated as to prevent C' fixation. Preheating serum, 
incubating at 0°C, and incubating in the presence of EDTA effectively dimin- 
ished chemotactic factor generation. When incubation was first carried out at 
0°C and then at 37°C,  activity was restored. These tests suggested that the 
generation of the chemotactic factor in serum was enzymatic in nature and 
demonstrated  that  this  generation  required  a  heat-labile,  cation-dependent 
serum system. A second line of evidence implicating C' was the lack of chemo- 
tactic factor generation by the endotoxoid preparation.  This preparation was 
chemically modified so as to lose certain toxicities and C'-fixing abilities which 
could be restored by adding specific anti-endotoxin serum (15, 25). In the pres- 
ent experiment, when rabbit anti-&  nw.rcescens  antibody was  added to  the 
endotoxoid preparation,  both chemotaxis-generating and  C'-fixing properties 
in normal guinea pig serum were restored. The third line of evidence implicating 
the C' system was the lack of chemotactic factor generation by LPS in C'- 
deficient mouse serum while the serum of the coisogenic, non-C'-deficient strain 
supported chemotactic factor generation by LPS. The "old" strain was found 
to be deficient in a euglobulin designated Hd which was present in the "new" 
strain (29). It was furthermore found that the presence of this protein was re- 
lated to a single gene (30). This euglobulin was found to be analogous to human 
C'5 (18). New line mouse sera when incubated with endotoxin generated chemo- 
tactic factor, but the C'5 deficient old strain serum under the same conditions 
did not. This finding implicated C'5  and/or components terminal to C'5  as 
being associated with the LPS-generated chemotactic factor. 
Ward has recently described two different chemotactic factors derived from 
the C' system. The first of these was a  trimolecular complex of C'5, C'6, and 
C'7 (10, 11). The second factor described was a "split" product of C'3, generated 
upon interaction of this component with plasmin (13).  The C'3 split product 
was  of low molecular weight (6000) and heat labile,  while the  trimolecular 
complex was described as being of high molecular weight (>300,000)  and heat 
stable. The LPS-generated chemotactic factor was heat stable, nondialyzable, 
and dependent on at least the C'5 component of the C' system, and on this basis 
we initially thought it might be analogous to the trimolecular complex. We 
found, however, that when the chemotactic factor generated by LPS in whole 
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tion volume was between that of hemoglobin  and cytochrome c. This suggested 
a molecular weight between 15,000 and 30,000 when plotted on a K~v vs. molec- 
ular weight scale for G-100 Sephadex (28). Sucrose density gradient separation 
of LPS-induced chemotactic factor using similar  molecular markers supported 
the  chromatographic  findings.  On  the  basis  of molecular  weight,  the LPS- 
induced chemotactic factor appears different from previously described chemo- 
tactic factors derived from the C' system. Whether this is the result of species 
difference, mode of activation, or other factors is under investigation. 
LPS-induced chemotactic factor could well be a product derived from one of 
the C' components terminal to C~3, perhaps C'5. This view is supported by the 
finding  of an inability to generate chemotactic factor by LPS in C'5-defieient 
mouse serum.  Further insights  will be gained by the use of purified C' compo- 
nents to study the interaction of LPS with the C' system. The mechanism of 
generation of a low molecular weight chemotactic factor might be analogous to 
recently proposed mechanisms of anaphylatoxin generation (31-33). Two prod- 
ucts with anaphylatoxin activities have been shown to be "split" products of 
C' system components. One was a derivative of C'3, while  the other was de- 
rived from C'5. 
During activation of the C' system by immune precipitates,  endotoxins,  or 
products liberated during hemostasis (13), a number of biologically active prod- 
ucts might be liberated  from the terminal  components of complement.  Endo- 
toxin-induced chemotactic factor could be among these  C~-derived products. 
Anaphylatoxin generation by LPS in fresh serum has recently also been shown 
to be C  ~ dependent (34) and similarly  might be released along with the chemo- 
tactic factor upon endotoxin-serum interaction.  Such products could initiate 
certain of the inflammatory processes with which endotoxin has been associated. 
Thus, the present study supports the hypothesis that the C t system mediates 
certain aspects of the inflammatory process induced by endotoxin by releasing 
biologically active products. 
Endotoxic lipopolysaccharide has recently been shown to fix large amounts of 
the complement components related to the biologic activities mediated by that 
system.  The  present  study sought  to  determine  whether  the  generation  of 
chemotactic factor by endotoxin in  serum was dependent upon complement 
system activation. 
Preheating serum, incubating at 0°C, or incubating in the presence of EDTA, 
all prevented chemotactic factor generation as well as complement fixation by 
endotoxin.  "Endotoxoids"  deficient  in  complement-fixing  activity were  also 
deficient in  chemotactic factor generation.  Chemotactic factor could not be 
generated by endotoxin in sera of mice congenitally deficient in the C~5 compo- 
nent of complement, while chemotactic factor was generated by endotoxin in 
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The chemotactic factor induced by endotoxin was heat stable and nondialyza- 
ble. Molecular sieve chromatography and sucrose density gradient ultracentri- 
fugation demonstrated that the chemotactic factor was a relatively low molecu- 
lar  weight  product  (15,000-30,000)  and  as  such  different  from  previously 
scribed C' system-derived chemotactic factors. 
These  experiments  demonstrate  that  generation  of  chemotactic  factor  by 
endotoxin in serum is dependent upon C ~ system activation involving at least 
C'5.  Furthermore,  the  relatively low molecular weight of this factor suggests 
that it  might be  derived  from activation  of a  single  complement component 
rather than from complexing of nmltiple complement components. 
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